In vitro/In vivo Study of Anti-inflammatory Effect of Cyperus rotundus on Diabetic Complications

Authors

  • Jayashree S.
  • Chaithra C.

Abstract

The reactive oxygen species (ROS) develop oxidative stress that contributes to the cause of human diseases. Radicals which enhance inflammation are nitric oxide, hydroxyl radical, hydrogen peroxide, and superoxide. Anion mediate and amplify the inflammation process, mediate vascular permeability and platelet aggregation leading to diabetic complications due to disruption of steady state of pro-oxidants and antioxidants. Cyperus rotundus plant extract was subjected to foraging radical activity with hemolysate sample to prove the antioxidant and anti-inflammatory properties in prevention of diabetic retinopathy (DR). The present study results showed that the compounds in the extract react with NO and prevent the nitrite and peroxynitrite anions generation. Thus the scavenging activity of NO by the extract acts as a supplementation of antioxidants. Also the Aldose reductase (AR) inhibitory activity of extract with various concentrations was carried out with rat eye lens of 9 week old male rats whose results exhibited with an IC50 73.2 µg/ml. Thus C.rotundus extract used for the investigation holds all the phytochemicals which are proven to have inhibitory effect on oxidative damage and suppresses AR activity which is the main enzyme in onset of DR.

 

Keywords: Cyprus rotundus, nitric oxide radical (NOR), diabetes, aldose reductase inhibitor (ARI)

Cite this Article

Jayashree S, Chaithra C. In vitro/In vivo Study of Anti-inflammatory Effect of Cyperus rotundus on Diabetic Complications. Research & Reviews: A Journal of Life Sciences. 2019; 9(Issue 1 Special): 24s–32s.

Downloads

Published

2019-06-25

Issue

Vol. 9 No. 1 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.